Cite
APA Citation
Lapointe, R., Jamal, R., van Kempen, L., Thebault, P., Belanger, K., Friedmann, J., Ayoub, J., Cocolakis, E., Kazemi, S., Dionne, J., Lambert, C., Le, H., Grange, C., Cailhier, J., Spatz, A., & Miller, W. (n.d.). immune biomarker correlates from a Phase II study of ipilimumab (IPI) with carboplatin and paclitaxel (CP) in patients with unresectable stage III or IV metastatic melanoma (MM). Journal for immunotherapy of cancer, 3, . http://access.bl.uk/ark:/81055/vdc_100135176430.0x000005